Search Results - "Subramaniam, Rathan"

Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis by Wass, Grayson, Clifford, Kari, Subramaniam, Rathan M

“…Fibroblast-activation protein is a promising target for oncologic molecular imaging. Studies show that fibroblast activation protein inhibitor (FAPI)…”
Get full text

Brain PET in the Diagnosis of Alzheimer’s Disease by Marcus, Charles, Mena, Esther, Subramaniam, Rathan M

“…OBJECTIVESThe aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose…”
Get full text

Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer by Kandathil, Asha, Kay, Fernando U, Butt, Yasmeen M, Wachsmann, Jason W, Subramaniam, Rathan M

“…Lung cancer is the leading cause of cancer-related mortality in the United States, and accurate staging plays a vital role in determining prognosis and…”
Get full text

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) by Yom, Sue S, Torres-Saavedra, Pedro, Caudell, Jimmy J, Waldron, John N, Gillison, Maura L, Xia, Ping, Truong, Minh T, Kong, Christina, Jordan, Richard, Subramaniam, Rathan M, Yao, Min, Chung, Christine H, Geiger, Jessica L, Chan, Jason W, O'Sullivan, Brian, Blakaj, Dukagjin M, Mell, Loren K, Thorstad, Wade L, Jones, Christopher U, Banerjee, Robyn N, Lominska, Christopher, Le, Quynh-Thu

“…Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus-associated oropharyngeal squamous…”
Get full text

(18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis by Perng, Powell, Marcus, Charles, Subramaniam, Rathan M

“…Monoclonal antibodies that target the programmed cell death 1 (PD-1) immune checkpoint protein and its associated ligands, PD-L1 and PD-L2, and targeted…”
Get full text

FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma by Kandathil, Asha, Subramaniam, Rathan M.

“…Lung cancer is the leading cause of cancer-related mortality in the United States. Accurate staging at initial diagnosis determines appropriate treatment and…”
Get full text

FDG‐PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta‐Analysis of Diagnostic Accuracy Studies by Sheikhbahaei, Sara, Trahan, Tyler J., Xiao, Jennifer, Taghipour, Mehdi, Mena, Esther, Connolly, Roisin M., Subramaniam, Rathan M.

“…Introduction. This study compared the diagnostic test accuracy of magnetic resonance imaging (MRI) with that of 18F‐fluoro‐2‐glucose‐positron emission…”
Get full text

Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology: Head and Neck Cancer by Subramaniam, Rathan M

“…During the last 2 decades, f-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F FDG PET/CT) has transformed the clinical head and neck…”
Get full text

Beyond the AJR : FDG PET/CT May Impact Surgical Management of Oral Cavity Squamous Cell Carcinoma Given High NPV for Detection of Neck Nodal Metastases by Subramaniam, Rathan M, Marcus, Charles

Get full text

Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials- 68 Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177 Lu-PSMA-617 Therapy by Subramaniam, Rathan M

Get full text

Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer by Goel, Reema, Moore, William, Sumer, Baran, Khan, Saad, Sher, David, Subramaniam, Rathan M

“…The purpose of this article is to summarize the evidence for the value of PET/CT for the management of patients with head and neck squamous cell cancer and…”
Get full text

Quarter Century Clinical PET/Computed Tomography: Transforming Medical Oncology Practice by Subramaniam, Rathan M.

Get full text

Role of Non-FDG-PET/CT in Head and Neck Cancer by Marcus, Charles, Subramaniam, Rathan M.

“…Head and neck cancers are commonly encountered malignancies in the United States, of which the majority are attributed to squamous cell carcinoma…”
Get full text

Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management by Kuyumcu, Serkan, Sanli, Yasemin, Subramaniam, Rathan M

“…Fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAFs), is a novel target for molecular imaging of various tumors…”
Get full text

Section Editor's Notebook: 68 Ga- and 177 Lu-DOTATATE Theragnostics-Personalized Care and Improving Patient Outcomes by Subramaniam, Rathan M

Get full text

Neuroendocrine Neoplasms: Molecular Imaging and Therapy by Subramaniam, Rathan M.

Get full text

Brain FDG PET and the diagnosis of dementia by Shivamurthy, Veeresh K N, Tahari, Abdel K, Marcus, Charles, Subramaniam, Rathan M

“…We review the role of brain FDG PET in the diagnosis of Alzheimer disease, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia…”
Get full text

Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice by Kandathil, Asha, Sibley, Robert Carson, Subramaniam, Rathan M

“…OBJECTIVEThe purpose of this article is to summarize the clinical utility of 18F-FDG PET/CT in the evaluation of lung cancer recurrence with an emphasis on…”
Get full text

The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer by Sheikhbahaei, Sara, Mena, Esther, Yanamadala, Anusha, Reddy, Siddaling, Solnes, Lilja B, Wachsmann, Jason, Subramaniam, Rathan M

“…The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and…”
Get full text

Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis by Subramaniam, Rathan M, Suarez-Cuervo, Catalina, Wilson, Renee F, Turban, Sharon, Zhang, Allen, Sherrod, Cheryl, Aboagye, Jonathan, Eng, John, Choi, Michael J, Hutfless, Susan, Bass, Eric B

“…N-acetylcysteine, sodium bicarbonate, statins, and ascorbic acid have been studied for reducing contrast-induced nephropathy (CIN). To evaluate the comparative…”
Get full text